Markets /ENDP Endo International plc ENDP Full chart Compare Add to watchlist Set alert Price alert · ENDP Alert when the price is Price abovePrice below Price level Set alert All alert types 0.37 +0.37 Day range unavailable 52-week range unavailable Overview Chart Financials FinancialsValuation & healthEarnings EarningsDividends & splitsAnalysts News Ownership Options More ComparisonSignalsTrend ScoreDiscussionNotesPositionsAlerts FinancialsValuation & health Revenue history · Free cash flow history OverviewIncome statementBalance sheetCash flow Revenue & Expenses AnnualQuarterly Revenue by Segment FY 2021FY 2020FY 2019FY 2018 Sterile Injectables → Revenue: $1.27BRevenue → Gross Profit: $1.77BGross Profit → Expenses: $1.77BRevenue → Cost of Revenue: $1.22BExpenses → Selling, General & Admin: $861.76MExpenses → Research & Development: $148.56MExpenses → Interest Expense: $562.35MExpenses → Other Expenses: $746.07MExpenses → Income Tax: $22.48MBranded Pharmaceuticals → Revenue: $893.62MNet Loss → Expenses: $569.08MGeneric Pharmaceuticals → Revenue: $740.59MInternational Pharmaceuticals → Revenue: $92.91MGross Profit$1.77BNet Loss$569.08MCost of Revenue$1.22BExpenses$2.34BSelling, General & Admin$861.76MResearch & Development$148.56MInterest Expense$562.35MOther Expenses$746.07MIncome Tax$22.48MRevenue$2.99BSterile Injectables$1.27BBranded Pharmaceuticals$893.62MGeneric Pharmaceuticals$740.59MInternational Pharmaceuticals$92.91M No annual statement lines ENDP has no annual lines for this statement.
